Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Could a new scope improve bowel surgery for endometriosis?

NCT ID NCT07523308

Symptom relief Sponsor: Obstetrics & Gynecology Hospital of Fudan University Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now This study
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study tests a new surgical technique called intra-operative dual laparoscopy and neo-rectoscopy (IDLnR) for treating bowel endometriosis. Researchers will compare it to standard laparoscopic surgery in 192 women aged 18-55. The goal is to see if the new method leads to better bowel function and quality of life six months after surgery.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
surgical procedure (intra-operative dual laparoscopy and neo-rectoscopy vs conventional laparoscopy)
What this could lead to
If successful, this new surgical technique could become a standard approach for bowel endometriosis, leading to better bowel function and quality of life after surgery.
What could go wrong
This is a relatively small, early-stage trial (192 participants) comparing two surgical methods. The new technique may not prove significantly better than the standard approach, and surgery always carries risks like infection or complications.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

About 192 people

The number the study aims to enrol. It can still change while the study runs.

Started

Apr 2026

Expected to finish

May 2028

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 to 55 years

Sex

Female participants only

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Premenopausal women aged 18 to 55 years. * Preoperative pelvic contrast-enhanced MRI and/or transrectal endosonography confirmed bowel endometriosis (BE) lesions involving the muscular layer of the intestinal wall, located in the rectum and/or sigmoid colon. Postoperative pathological diagnosis serves as the gold standard. * Pre-treatment LARS score \> 20. * Eligible for laparoscopic surgery. * Voluntarily participated in this study and signed written informed consent Exclusion Criteria: * Pregnancy or lactation. * Presence of active inflammatory bowel disease, irritable bowel syndrome, or other similar conditions with disease flare-ups within the past 1 year. * Acute or severe infectious disease within 4 weeks prior to surgery. * History of malignant tumor, or highly suspected gynecological/gastrointestinal malignancy based on preoperative imaging or tumor marker tests. * American Society of Anesthesiologists (ASA) physical status classification ≥ Grade Ⅲ, or severe cardiac, pulmonary, hepatic, renal, or coagulation dysfunction that precludes general anesthesia and elective laparoscopic surgery. * Undergoing robot-assisted laparoscopic surgery or open laparotomy. * Currently participating in other clinical trials that may affect the outcome assessment of this study. * Previous participation in other interventional clinical trials that may affect the outcome assessment of this study. * History of colorectal resection and anastomosis or stoma surgery. * History of pelvic radiotherapy.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Bowel endometriosis are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

endometriosis endometriosis of intestine

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Bowel endometriosis Endometriosis Intestinal endometriosis

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    3 sites. The list below names each one and where it is.

  2. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • International Peace Maternity and Child Health Hospital

    NOT_YET_RECRUITING

    Shanghai, Shanghai Municipality, 200030, China

  • Obstetrics and Gynecology Hospital of Fudan University

    RECRUITING

    Shanghai, Shanghai Municipality, 201101, China

  • Shanghai First Maternity and Infant Hospital

    NOT_YET_RECRUITING

    Shanghai, Shanghai Municipality, 201101, China

More trials for these conditions

Other studies related to the condition(s) this trial covers.